Login/Sign Up
MRP ₹1500
(Inclusive of all Taxes)
₹225.0 Cashback (15%)
Provide Delivery Location
About Darbosis 25Mcg/0.42Ml Inj
Darbosis 25Mcg/0.42Ml Inj belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Darbosis 25Mcg/0.42Ml Inj helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.
Darbosis 25Mcg/0.42Ml Inj contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Darbosis 25Mcg/0.42Ml Inj is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Darbosis 25Mcg/0.42Ml Inj stimulates the production of this protein in the bone marrow.
Darbosis 25Mcg/0.42Ml Inj will be injected by the healthcare provider. Do not self-administer. The most common side effects of Darbosis 25Mcg/0.42Ml Inj are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Darbosis 25Mcg/0.42Ml Inj do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Darbosis 25Mcg/0.42Ml Inj to avoid any complications. Also, mention all the other medications you are taking to affect the way Darbosis 25Mcg/0.42Ml Inj works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Darbosis 25Mcg/0.42Ml Inj.
Uses of Darbosis 25Mcg/0.42Ml Inj
Darbosis 25Mcg/0.42Ml Inj is used in the treatment of Anaemia (in cancer and chronic kidney disease). The detailed uses of Darbosis 25Mcg/0.42Ml Inj are as follows:
Have a query?
Directions for Use
Medicinal Benefits
Darbosis 25Mcg/0.42Ml Inj is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn cause low red blood cells count causing anaemia. This medicine is primarily indicated for treating anaemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells' cancer. Darbosis 25Mcg/0.42Ml Inj contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells.
How Darbosis 25Mcg/0.42Ml Inj Works
Storage
What if I have taken an overdose of Darbosis 25Mcg/0.42Ml Inj
Drug Warnings
Darbosis 25Mcg/0.42Ml Inj can enhance the risk of serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may also shorten survival time in some people with certain types of cancer. Inform your doctor before taking Darbosis 25Mcg/0.42Ml Inj if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take Darbosis 25Mcg/0.42Ml Inj if you are pregnant or breastfeeding unless prescribed by the doctor. Darbosis 25Mcg/0.42Ml Inj may affect a person's ability to drive as it may cause convulsion during initial days of treatment, so a person taking Darbosis 25Mcg/0.42Ml Inj should avoid driving or operating any machine. Darbosis 25Mcg/0.42Ml Inj should not be given to children below 12 years of age, as safety and effectiveness have not been established. Avoid consuming alcohol along with Darbosis 25Mcg/0.42Ml Inj as it could lead to increased dizziness and sleepiness.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Unsafe
Avoid consumption of alcohol while taking Darbosis 25Mcg/0.42Ml Inj as it may increase dizziness and sleepiness.
Pregnancy
Caution
Avoid taking Darbosis 25Mcg/0.42Ml Inj if you are pregnant unless prescribed by a doctor as Darbosis 25Mcg/0.42Ml Inj is a pregnancy category C drug. Please consult your doctor if you have any concerns regarding this, your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Consult your doctor before taking Darbosis 25Mcg/0.42Ml Inj; your doctor will decide whether Darbosis 25Mcg/0.42Ml Inj can be taken by breastfeeding mothers or not.
Driving
Unsafe
Darbosis 25Mcg/0.42Ml Inj causes convulsions (seizures), especially during the initial months of treatment. So, it is better not to drive or operate machinery unless you are alert.
Liver
Caution
Dose adjustment may be needed in patients with liver impairment. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Dose adjustment may be needed in patients with kidney impairment. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Caution
Darbosis 25Mcg/0.42Ml Inj should not be given to children as the safety and efficacy have not been established.
Darbosis 25Mcg/0.42Ml Inj is used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Darbosis 25Mcg/0.42Ml Inj helps to reverse anaemia and reduce the need for blood transfusion.
It is suggested to store the Darbosis 25Mcg/0.42Ml Inj in the refrigerator and protect it from light. However, a person should not freeze it.
It is advised to tell your doctor about your medical conditions like heart disease, high blood pressure, kidney disease, a stroke, heart attack, or blood clot, a seizure, a latex allergy to avoid any type of medical condition.
A person who is allergic to any chemical compound present in Darbosis 25Mcg/0.42Ml Inj or have uncontrolled/untreated high blood pressure, or ever had pure red cell aplasia (a type of anaemia) caused by using darbepoetin alfa, or epoetin alfa is not allowed to take a name.
Consult your doctor before taking Darbosis 25Mcg/0.42Ml Inj if you are pregnant or planning for pregnancy. Your doctor will prescribe Darbosis 25Mcg/0.42Ml Inj only if the benefits outweigh the risks.
Darbosis 25Mcg/0.42Ml Inj contains a protein "Darbepoetin alfa", which works by providing signals to the bone marrow to make more red blood cells. As in chronic kidney disease, the kidney gets damaged and doesn't filter the blood in the way it should be leading to anemia.
Darbosis 25Mcg/0.42Ml Inj may cause side effects such as injection site pain, cough, low blood pressure, headache, diarrhoea, body pains, shortness of breath or stomach pain. If these side effects persist or worsen, please consult your doctor.
After beginning treatment with Darbosis 25Mcg/0.42Ml Inj, it takes around 2 to 6 weeks for increase in haemoglobin level in blood.
Darbosis 25Mcg/0.42Ml Inj is used only if anaemia is due to chronic (long term) kidney disease and chemotherapy for some types of cancer (except for bone marrow and blood cells).
Darbosis 25Mcg/0.42Ml Inj may cause high blood pressure particularly in patients with long term kidney disease due to the rapid increase of red blood cells in the initial 3 months after starting Darbosis 25Mcg/0.42Ml Inj.
Darbosis 25Mcg/0.42Ml Inj is not used in the treatment of cancer. It is used in treatment of anemia (low levels of healthy red blood cells) in patients receiving chemotherapy for some types of cancer (except for bone marrow or blood cells cancer).
Darbosis 25Mcg/0.42Ml Inj should be used with extreme caution as it can cause serious side effects and can even be life-threatening. The patient should follow doctor’s recommendations strictly.
If you have deficiencies of folic acid, vitamin B12 or iron, you may not respond to Darbosis 25Mcg/0.42Ml Inj. It is important that you take measures to correct these deficiencies. Other reasons may be infections, bleeding, inflammation and bone marrow fibrosis. If you have any concerns, consult your doctor.
Darbosis 25Mcg/0.42Ml Inj is usually not recommended for children as the safety and effectiveness were not established. However, if you have any concerns regarding the use of Darbosis 25Mcg/0.42Ml Inj for children, please consult your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information